Clinical Trial Update: Cefixime Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of cefixime is evaluating its use for syphilis and HIV infection. Recruitment is ongoing at the University of Southern California.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Syphilis

Drugs mentioned

• CEFIXIME (cefixime)

Snippet

Sponsor: University of Southern California | Conditions: Syphilis, Human Immunodeficiency Virus | Phase 3 | Status: RECRUITING